Top Markets
Coin of the day
Spago Nanomedical AB (publ) Spago Nanomedical AB (publ)

Spago Nanomedical AB (publ)

SPAGO
Clasificación en acciones #32286
Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to... Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to pioneering nanomedicines for both the diagnosis and treatment of cancer. The company is actively pursuing two key projects: the SpagoPix initiative, centered on SN132D, a gadolinium-free MRI contrast agent developed for imaging breast and pancreatic cancers; and the Tumorad project, which is advancing SN201, a radionuclide therapy intended for managing advanced and metastatic forms of cancer. Originally established as Spago Imaging AB (publ), the company adopted its current name, Spago Nanomedical AB (publ), in May 2014. Founded in 1999, its base of operations is situated in Lund, Sweden.
Precio por acción
$0.01317984
Última sincronización: 2026-08-17
Capitalización bursátil
$10.52M
Cambio (1 día)
-1.26%
Cambio (1 año)
-53.51%
País
SE
Comercio Spago Nanomedical AB (publ) (SPAGO)

Categoría

Ratio P/S de Spago Nanomedical AB (publ) (SPAGO)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Spago Nanomedical AB (publ), el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Spago Nanomedical AB (publ) desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
10.17 -
US
10.13 -
NL
2.95 -
AU
- -
CH
- -
KR